Mirador Capital Partners LP Raises Position in UnitedHealth Group Incorporated $UNH

Key Points

• Mirador Capital Partners LP raised its stake in UnitedHealth by 1,738.5% in Q4 to 24,949 shares (worth about $8.24 million), making UNH roughly 1.1% of Mirador’s holdings and its 20th‑largest position.
• Institutional ownership of UNH stands at 87.86%, with major investors such as Norges Bank, Capital Research, Berkshire Hathaway and Dodge & Cox adding or establishing multi‑billion‑dollar positions.
• UnitedHealth launched Avery, a generative AI member‑navigation tool that could lower service costs and boost engagement; analysts are mixed—consensus is a "Moderate Buy" with a $372.13 price target—while the company recently beat EPS estimates and pays a 3.4% dividend.

Mirador Capital Partners LP lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 1,738.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,949 shares of the healthcare conglomerate's stock after purchasing an additional 23,592 shares during the period. UnitedHealth Group accounts for approximately 1.1% of Mirador Capital Partners LP's holdings, making the stock its 20th largest position. Mirador Capital Partners LP's holdings in UnitedHealth Group were worth $8,236,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Norges Bank purchased a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $3,837,207,000. Capital Research Global Investors raised its stake in UnitedHealth Group by 126.9% during the 3rd quarter. Capital Research Global Investors now owns 13,042,049 shares of the healthcare conglomerate's stock worth $4,503,419,000 after acquiring an additional 7,293,009 shares during the period. Berkshire Hathaway Inc purchased a new position in UnitedHealth Group during the second quarter valued at approximately $1,572,193,000. Dodge & Cox increased its stake in shares of UnitedHealth Group by 117.7% in the second quarter. Dodge & Cox now owns 8,750,560 shares of the healthcare conglomerate's stock worth $2,729,912,000 after purchasing an additional 4,730,192 shares in the last quarter. Finally, Capital World Investors lifted its stake in shares of UnitedHealth Group by 18.8% during the 3rd quarter. Capital World Investors now owns 21,766,922 shares of the healthcare conglomerate's stock valued at $7,516,107,000 after buying an additional 3,439,182 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealthcare rolled out Avery, a generative AI companion aimed at simplifying member navigation, improving self‑serve capabilities and helping customer advocates handle requests more efficiently—this could boost engagement, lower service costs and improve retention if adoption scales. UnitedHealthcare introduces Avery generative AI companion
• Positive Sentiment: Analyst commentary highlights Avery’s potential to “redefine healthcare navigation at scale,” reinforcing the strategic case that AI-driven workflows could materially improve member experience and operational efficiency over time. Can UnitedHealth's Avery Redefine Healthcare Navigation at Scale?
• Positive Sentiment: Erste Group nudged up its FY2027 EPS forecast slightly, suggesting some analyst conviction in UnitedHealth’s earnings trajectory despite recent volatility. Small estimate upgrades can support the longer‑term earnings story. UNH Valuation / Analyst Note (MarketBeat)
• Neutral Sentiment: Several outlets note analysts’ average rating as “Moderate Buy,” indicating consensus caution rather than strong conviction; useful context for positioning but not an immediate catalyst. UnitedHealth Given Average Rating of "Moderate Buy" by Analysts
• Neutral Sentiment: Zacks flagged UNH as a trending stock, summarizing factors investors should watch (scale, guidance, valuation) — informative for sentiment monitoring rather than a direct price driver. UNH Is a Trending Stock: Facts to Know
• Neutral Sentiment: Coverage in a mega‑cap roundup highlights UNH’s dominant position and limited upside from scale—useful framing for portfolio managers evaluating risk/return among large-cap names. 1 Mega-Cap Stock with Exciting Potential and 2 We Question
• Negative Sentiment: Analysts expect a single‑digit profit decline in UnitedHealth’s upcoming fiscal Q1 report, which can pressure near‑term multiples and sentiment if results follow the projection. Here's What to Expect From UnitedHealth's Next Earnings Report
• Negative Sentiment: Recent coverage pointing to weak recent share performance and a valuation check highlights market concern over the stock’s discount from prior highs and whether growth can reaccelerate—a likely contributor to today’s sell‑off. UnitedHealth Group (UNH) Valuation Check After Recent Weak Share Performance

Analysts Set New Price Targets

UNH has been the subject of a number of analyst reports. Weiss Ratings lowered UnitedHealth Group from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Monday, March 2nd. Oppenheimer cut their target price on UnitedHealth Group from $415.00 to $385.00 and set an "outperform" rating for the company in a research report on Wednesday, January 28th. Piper Sandler reissued an "overweight" rating on shares of UnitedHealth Group in a report on Tuesday, January 27th. Morgan Stanley cut their price objective on shares of UnitedHealth Group from $411.00 to $409.00 and set an "overweight" rating for the company in a report on Friday, January 23rd. Finally, Barclays dropped their target price on shares of UnitedHealth Group from $391.00 to $327.00 and set an "overweight" rating for the company in a research report on Friday, January 30th. One research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $372.13.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $259.15 on Friday. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.79. The company has a market cap of $235.23 billion, a price-to-earnings ratio of 19.65, a PEG ratio of 1.23 and a beta of 0.41. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $606.36. The stock's 50 day simple moving average is $290.39 and its two-hundred day simple moving average is $322.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, beating analysts' consensus estimates of $2.09 by $0.02. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The firm had revenue of $113.73 billion during the quarter, compared to analyst estimates of $113.38 billion. During the same period last year, the firm posted $6.81 earnings per share. UnitedHealth Group's revenue for the quarter was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Investors of record on Monday, March 9th were issued a $2.21 dividend. The ex-dividend date of this dividend was Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.4%. UnitedHealth Group's dividend payout ratio (DPR) is presently 67.02%.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.